http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2396441-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_882b5d32187f0f7eb237c7cdaf6acd1c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
filingDate 2001-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2004-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ae3c81981d7a2119b1dcad91d3c9f9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_030190d2d87275fe2b868c3e85ceb022
publicationDate 2004-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2396441-C
titleOfInvention Diclofenamide suspension gel
abstract The present invention relates to ophthalmic compositions in the form of suspension gels of the free acid of the diclofenamide for treating glaucoma. The invention also relates to the use of suspension gels containing the free acid of the diclofenamide for treating primary and/or secondary open-angle glaucomas, for reducing the intra-ocular pressure and for treating ocular hypertension.
priorityDate 2000-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413339604
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5455
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11556711
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513011
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5967
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453579081
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5333
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474364
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449880044

Total number of triples: 46.